Condition: Primary Hyperlipidemia · Sponsor: Gan & Lee Pharmaceuticals.
This trial is a phase III study to evaluate the efficacy , tolerability, and safety of Bempedoic Acid Tablets in patients with hyperlipidemia not adequately controlled by Statins.
This description comes directly from the study's public registry record.
Wei Zhao · 010-56456726 · wei.zhao@ganlee.com
Always discuss trial participation with your own doctor first.
| Site 01 | Beijing, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06780410